Schedule 13D ownership disclosure

Bicara Therapeutics Inc

Security class unavailable · CUSIP: 055477103

Event date: 2024-09-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,010,425
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-24-012103
Form type
SC 13D
Filer
Bicara Therapeutics Inc.
CIK
CIK 2023658
Filed
Sep 18, 2024
Reporting period
Sep 16, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub